This hub covers pediatric epilepsy in infants, kids, and teens, including diagnosis, syndromes, development, school plans, and safety. New studies translated into clear takeaways for parents.
Usually when two appropriate medications haven’t controlled seizures.
Many families benefit and it depends on seizure frequency, medications, and learning needs.
Often yes, with smart precautions. Ask your neurologist or epileptologist about your child’s specific risks.
Clusters, prolonged seizures, breathing trouble, new weakness, or major regression.
This study focused on children with a specific type of epilepsy called focal cortical dysplasia (FCD), which often does not respond to medication.
Researchers studied a group of children with epilepsy who might be candidates for surgery to help control their seizures.
The PREVeNT trial studied the effects of a medication called vigabatrin on infants with Tuberous Sclerosis Complex (TSC), a condition that often leads to epilepsy and developmental challenges.
A study was conducted to look at how effective Cenobamate (CNB) is for adults with idiopathic generalized epilepsy (IGE), a type of epilepsy that can be hard to treat.
This study looked at children with drug-resistant epilepsy, which means their seizures do not respond well to medication.
This study focused on women with epilepsy who are of childbearing age, a group that faces specific challenges related to their condition and reproductive health.
Researchers studied how two common antiepileptic drugs, valproic acid (VPA) and levetiracetam (LEV), affect hormone levels in adolescent girls with epilepsy.
This study looked at adults with drug-resistant epilepsy (DRE) who were treated with the modified Atkins diet (MAD) at a specialized clinic.
Researchers studied two young girls, ages 9 and 10, who experienced seizures triggered by a red-light flashing pen that is popular among children.